← FDA Drug Approvals (Drugs@FDA)

MEROPENEM

NDA · New Drug Application · Sponsor: HQ SPCLT PHARMA · Approved 2023-07-26

Drug application

FDA Application #

NDA215212

Application type

New Drug Application

Brand name

MEROPENEM

Generic name

MEROPENEM

Active ingredients

MEROPENEM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HQ SPCLT PHARMA

Manufacturer

WG Critical Care, LLC

First approval

2023-07-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown